Affordable Access

Publisher Website

Selective retinoids and rexinoids in cancer therapy and chemoprevention

Authors
Journal
Drug Discovery Today
1359-6446
Publisher
Elsevier
Publication Date
Volume
7
Issue
23
Identifiers
DOI: 10.1016/s1359-6446(02)02526-6
Keywords
  • Therapeutic Focus
Disciplines
  • Biology
  • Medicine

Abstract

Abstract Natural and synthetic retinoids are effective inhibitors of tumor cell growth in vitro and in vivo. However, the toxicity of natural derivatives of vitamin A limits their therapeutic use. Recently, synthetic compounds selective for the different retinoid receptor isotypes have been generated that circumvent pan-retinoid toxicity. The tumor-suppressive activity of selective retinoid and/or rexinoid ligands has been established preclinically, and emerging clinical trials are supportive of the chemotherapeutic and chemopreventive potential of these compounds in multiple oncology indications, with reduced toxicity. Moreover, the combination of retinoids and/or rexinoids with chemotherapeutic agents for the synergistic modulation of specific pathways could also be of benefit in cancer therapy.

There are no comments yet on this publication. Be the first to share your thoughts.